Literature DB >> 9770527

Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression.

S M Wahl1, T Greenwell-Wild, G Peng, H Hale-Donze, T M Doherty, D Mizel, J M Orenstein.   

Abstract

Infection with HIV-1 results in pronounced immune suppression and susceptibility to opportunistic infections (OI). Reciprocally, OI augment HIV-1 replication. As we have shown for Mycobacterium avium complex (MAC) and Pneumocystis carinii, macrophages infected with opportunistic pathogens and within lymphoid tissues containing OI, exhibit striking levels of viral replication. To explore potential underlying mechanisms for increased HIV-1 replication associated with coinfection, blood monocytes were exposed to MAC antigens (MAg) or viable MAC and their levels of tumor necrosis factor alpha (TNFalpha) and HIV-1 coreceptors monitored. MAC enhanced TNFalpha production in vitro, consistent with its expression in coinfected lymph nodes. Using a polyclonal antibody to the CCR5 coreceptor that mediates viral entry of macrophage tropic HIV-1, a subset of unstimulated monocytes was shown to be CCR5-positive by fluorescence-activated cell sorter analysis. After stimulation with MAg or infection with MAC, CCR5 expression was increased at both the mRNA level and on the cell surface. Up-regulation of CCR5 by MAC was not paralleled by an increase in the T cell tropic coreceptor, CXCR4. Increases in NF-kappaB, TNFalpha, and CCR5 were consistent with the enhanced production of HIV-1 in MAg-treated adherent macrophage cultures as measured by HIV-1 p24 levels. Increased CCR5 was also detected in coinfected lymph nodes as compared with tissues with only HIV-1. The increased production of TNFalpha, together with elevated expression of CCR5, provide potential mechanisms for enhanced infection and replication of HIV-1 by macrophages in OI-infected cells and tissues. Consequently, treating OI may inhibit not only the OI-induced pathology, but also limit the viral burden.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9770527      PMCID: PMC22872          DOI: 10.1073/pnas.95.21.12574

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

1.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

2.  Decay characteristics of HIV-1-infected compartments during combination therapy.

Authors:  A S Perelson; P Essunger; Y Cao; M Vesanen; A Hurley; K Saksela; M Markowitz; D D Ho
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

3.  Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection.

Authors:  T M Doherty; A Sher
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

4.  Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis.

Authors:  L M Wahl; I M Katona; R L Wilder; C C Winter; B Haraoui; I Scher; S M Wahl
Journal:  Cell Immunol       Date:  1984-05       Impact factor: 4.868

5.  Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity.

Authors:  S M Wahl; N McCartney-Francis; D A Hunt; P D Smith; L M Wahl; I M Katona
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

6.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

7.  Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages.

Authors:  J W Mellors; B P Griffith; M A Ortiz; M L Landry; J L Ryan
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

8.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes.

Authors:  A Sica; A Saccani; A Borsatti; C A Power; T N Wells; W Luini; N Polentarutti; S Sozzani; A Mantovani
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

10.  Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors.

Authors:  A Granelli-Piperno; B Moser; M Pope; D Chen; Y Wei; F Isdell; U O'Doherty; W Paxton; R Koup; S Mojsov; N Bhardwaj; I Clark-Lewis; M Baggiolini; R M Steinman
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

View more
  18 in total

1.  Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.

Authors:  J P Lai; W Z Ho; G X Zhan; Y Yi; R G Collman; S D Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen.

Authors:  S T Sadiq; J McSorley; A J Copas; J Bennett; S J Edwards; S Kaye; S Kirk; P French; I V D Weller
Journal:  Sex Transm Infect       Date:  2005-10       Impact factor: 3.519

3.  High glucose enhances HIV entry into T cells through upregulation of CXCR4.

Authors:  Xiqian Lan; Kang Cheng; Nirupama Chandel; Rivka Lederman; Aakash Jhaveri; Mohammad Husain; Ashwani Malhotra; Pravin C Singhal
Journal:  J Leukoc Biol       Date:  2013-08-02       Impact factor: 4.962

4.  Proline-proline-glutamic acid (PPE) protein Rv1168c of Mycobacterium tuberculosis augments transcription from HIV-1 long terminal repeat promoter.

Authors:  Khalid Hussain Bhat; Chinta Krishna Chaitanya; Nazia Parveen; Raja Varman; Sudip Ghosh; Sangita Mukhopadhyay
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

5.  Revising the Role of Myeloid cells in HIV Pathogenesis.

Authors:  Anupriya Aggarwal; Samantha McAllery; Stuart G Turville
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

6.  Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain.

Authors:  Susanna L Lamers; Marco Salemi; Derek C Galligan; Alanna Morris; Rebecca Gray; Gary Fogel; Li Zhao; Michael S McGrath
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

7.  Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation.

Authors:  Nancy Vázquez; Teresa Greenwell-Wild; Nancy J Marinos; William D Swaim; Salvador Nares; David E Ott; Ulrich Schubert; Peter Henklein; Jan M Orenstein; Michael B Sporn; Sharon M Wahl
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  Modulation of innate host factors by Mycobacterium avium complex in human macrophages includes interleukin 17.

Authors:  Nancy Vázquez; Sofia Rekka; Maria Gliozzi; Carl G Feng; Shoba Amarnath; Jan M Orenstein; Sharon M Wahl
Journal:  J Infect Dis       Date:  2012-08-28       Impact factor: 5.226

Review 9.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

10.  In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission.

Authors:  Charlene S Dezzutti; V Nicole James; Artur Ramos; Sharon T Sullivan; Aladin Siddig; Timothy J Bush; Lisa A Grohskopf; Lynn Paxton; Shambavi Subbarao; Clyde E Hart
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.